Freestone Grove Partners LP purchased a new position in National Vision Holdings, Inc. (NASDAQ:EYE – Free Report) in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 40,318 shares of the company’s stock, valued at approximately $766,000. Freestone Grove Partners LP owned approximately 0.05% of National Vision as of its most recent filing with the Securities & Exchange Commission.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. ProShare Advisors LLC raised its stake in National Vision by 3.0% during the fourth quarter. ProShare Advisors LLC now owns 15,145 shares of the company’s stock valued at $391,000 after buying an additional 438 shares in the last quarter. CWM LLC grew its position in shares of National Vision by 3.4% in the 4th quarter. CWM LLC now owns 15,565 shares of the company’s stock worth $402,000 after acquiring an additional 507 shares in the last quarter. Quantinno Capital Management LP grew its position in shares of National Vision by 2.3% in the 1st quarter. Quantinno Capital Management LP now owns 26,323 shares of the company’s stock worth $682,000 after acquiring an additional 586 shares in the last quarter. Lazard Asset Management LLC increased its holdings in shares of National Vision by 0.9% in the 2nd quarter. Lazard Asset Management LLC now owns 68,819 shares of the company’s stock valued at $1,583,000 after acquiring an additional 637 shares during the last quarter. Finally, HB Wealth Management LLC increased its holdings in shares of National Vision by 2.4% in the 1st quarter. HB Wealth Management LLC now owns 33,451 shares of the company’s stock valued at $866,000 after acquiring an additional 776 shares during the last quarter.
National Vision Price Performance
Shares of EYE opened at $17.38 on Friday. The firm has a market capitalization of $1.37 billion, a price-to-earnings ratio of 28.49, a price-to-earnings-growth ratio of 1.37 and a beta of 1.02. The company has a debt-to-equity ratio of 0.25, a quick ratio of 0.27 and a current ratio of 0.59. National Vision Holdings, Inc. has a one year low of $14.75 and a one year high of $30.02. The stock’s fifty day moving average is $19.84 and its 200-day moving average is $22.03.
Analyst Upgrades and Downgrades
Several brokerages recently issued reports on EYE. Bank of America reduced their price objective on National Vision from $35.00 to $30.00 and set a “buy” rating on the stock in a research note on Thursday, May 14th. Weiss Ratings downgraded shares of National Vision from a “hold (c)” rating to a “hold (c-)” rating in a research report on Tuesday. Barclays decreased their target price on National Vision from $38.00 to $27.00 and set an “overweight” rating for the company in a research note on Thursday, May 14th. UBS Group lowered their target price on National Vision from $36.00 to $34.00 and set a “buy” rating for the company in a report on Thursday, August 13th. Finally, Citigroup dropped their price target on National Vision from $39.00 to $35.00 and set a “buy” rating on the stock in a research report on Thursday, August 13th. Seven investment analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. According to data from MarketBeat, National Vision currently has an average rating of “Moderate Buy” and a consensus price target of $30.36.
Get Our Latest Analysis on EYE
National Vision Profile
National Vision Holdings, Inc is an American optical retailer specializing in accessible vision care and eyewear. The company operates under multiple retail banners, offering comprehensive eye health services and a wide range of optical products. Since its founding in the early 1990s, National Vision has focused on providing value-driven solutions, targeting underserved and price‐conscious consumer segments.
Through its primary retail brands—including America’s Best Contacts & Eyeglasses, Eyeglass World, Optical America and Vista Optical—National Vision delivers services such as comprehensive eye examinations, prescription eyewear, contact lenses, sunglasses and lens accessories.
See Also
- Five stocks we like better than National Vision
- From SaaS-pocalypse to Perfect Storm: Workday’s AI Growth Story Strengthens
- These 3 GARP Stocks Show Why Growth and Value Do Not Have to Clash
- Venture Into High-Volatility Corners of the Market With These 3 ETFs
- 3 Retail Stocks to Watch After a Big Consumer Earnings Week
Want to see what other hedge funds are holding EYE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for National Vision Holdings, Inc. (NASDAQ:EYE – Free Report).
Receive News & Ratings for National Vision Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Vision and related companies with MarketBeat.com's FREE daily email newsletter.
